Literature DB >> 19729159

Acute renal dysfunction following hip fracture.

Simon J Bennet1, Olivia M B Berry, Jane Goddard, John F Keating.   

Abstract

We investigated the incidence, risk factors and outcome of acute renal dysfunction (ARD) in patients with a fractured neck of femur. 170 consecutive patients were prospectively included in the Scottish Hip Fracture Audit database and retrospectively analysed. Historically, lack of consensus definition has hindered accurate reporting of ARD. ARD was defined using the 'RIFLE' criteria. 27 patients (16%) developed ARD. Risk factors were male sex, vascular disease, hypertension, diabetes, chronic kidney disease and pre-morbid use of nephrotoxic medications (p<0.01). Inpatient, 30- and 120-day mortality was higher in the ARD group 19%, 22% and 41% respectively, versus 0%, 4% and 13% in the non-ARD group (p<0.01). Length of hospital stay was significantly longer in the ARD group. Pre- and post-operative complications were 12 and 5 times more frequent respectively in the ARD group (p<0.01). Awareness of risk factors and serial measurements of renal function allow early identification and focused monitoring of these patients. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729159     DOI: 10.1016/j.injury.2009.07.009

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  29 in total

1.  Perioperative management of patients with connective tissue disease.

Authors:  Susan M Goodman; Mark P Figgie; C Ronald Mackenzie
Journal:  HSS J       Date:  2010-08-17

2.  Renal and Gastrointestinal Considerations in Joint Replacement Surgery.

Authors:  Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh
Journal:  J Nat Sci       Date:  2015-02-01

3.  Rate and Outcome of Acute Kidney Injury Following Hip Fracture Surgery in Diabetic Older Patients Treated with Renin-Angiotensin-Aldosterone Antagonists.

Authors:  Tal Frenkel Rutenberg; Abdelazeez Bdeir; Benaya Rozen-Zvi; Yoav Rosenthal; Steven Velkes; Avraham Weiss; Yichayaou Beloosesky
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

Review 4.  Prognostic factors of in-hospital complications after hip fracture surgery: a scoping review.

Authors:  K J Sheehan; E M Guerrero; D Tainter; B Dial; R Milton-Cole; J A Blair; J Alexander; P Swamy; L Kuramoto; P Guy; J P Bettger; B Sobolev
Journal:  Osteoporos Int       Date:  2019-04-29       Impact factor: 4.507

Review 5.  Major comorbid disease processes associated with increased incidence of acute kidney injury.

Authors:  Salwa Farooqi; Jeffrey G Dickhout
Journal:  World J Nephrol       Date:  2016-03-06

6.  Risk factors and associated outcomes of acute kidney injury in hip fracture patients.

Authors:  Abhishek Ganta; Rown Parola; Cody R Perskin; Sanjit R Konda; Kenneth A Egol
Journal:  J Orthop       Date:  2021-07-26

7.  Which patients are at risk for kidney dysfunction after hip fracture surgery?

Authors:  George A Macheras; Konstantinos Kateros; Stefanos D Koutsostathis; Stamatios A Papadakis; Eleftherios Tsiridis
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

8.  Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals.

Authors:  Cagatay Ulucay; Zehra Eren; Elif Cigdem Kaspar; Turhan Ozler; Korcan Yuksel; Gulcin Kantarci; Faik Altintas
Journal:  Geriatr Orthop Surg Rehabil       Date:  2012-12

9.  Value of routine blood tests for prediction of mortality risk in hip fracture patients.

Authors:  Mathias Mosfeldt; Ole B Pedersen; Troels Riis; Henning O Worm; Susanne van der Mark; Henrik L Jørgensen; Benn R Duus; Jes B Lauritzen
Journal:  Acta Orthop       Date:  2012-01-17       Impact factor: 3.717

10.  Analysis of kidney dysfunction in orthopaedic patients.

Authors:  Konstantinos Kateros; Christos Doulgerakis; Spyridon P Galanakos; Vasileios I Sakellariou; Stamatios A Papadakis; George A Macheras
Journal:  BMC Nephrol       Date:  2012-09-03       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.